• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病发病机制中的氧化应激与突触功能障碍:理解治疗策略

Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.

作者信息

Kamat Pradip K, Kalani Anuradha, Rai Shivika, Swarnkar Supriya, Tota Santoshkumar, Nath Chandishwar, Tyagi Neetu

机构信息

Division of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, KY, 40202, USA.

Division of Pharmacology, Central Drug Research Institute (CDRI), P.O. Box 173, Lucknow, 226001, UP, India.

出版信息

Mol Neurobiol. 2016 Jan;53(1):648-661. doi: 10.1007/s12035-014-9053-6. Epub 2014 Dec 17.

DOI:10.1007/s12035-014-9053-6
PMID:25511446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4470891/
Abstract

Synapses are formed by interneuronal connections that permit a neuronal cell to pass an electrical or chemical signal to another cell. This passage usually gets damaged or lost in most of the neurodegenerative diseases. It is widely believed that the synaptic dysfunction and synapse loss contribute to the cognitive deficits in patients with Alzheimer's disease (AD). Although pathological hallmarks of AD are senile plaques, neurofibrillary tangles, and neuronal degeneration which are associated with increased oxidative stress, synaptic loss is an early event in the pathogenesis of AD. The involvement of major kinases such as mitogen-activated protein kinase (MAPK), extracellular receptor kinase (ERK), calmodulin-dependent protein kinase (CaMKII), glycogen synthase-3β (GSK-3β), cAMP response element-binding protein (CREB), and calcineurin is dynamically associated with oxidative stress-mediated abnormal hyperphosphorylation of tau and suggests that alteration of these kinases could exclusively be involved in the pathogenesis of AD. N-methyl-D-aspartate (NMDA) receptor (NMDAR) activation and beta amyloid (Aβ) toxicity alter the synapse function, which is also associated with protein phosphatase (PP) inhibition and tau hyperphosphorylation (two main events of AD). However, the involvement of oxidative stress in synapse dysfunction is poorly understood. Oxidative stress and free radical generation in the brain along with excitotoxicity leads to neuronal cell death. It is inferred from several studies that excitotoxicity, free radical generation, and altered synaptic function encouraged by oxidative stress are associated with AD pathology. NMDARs maintain neuronal excitability, Ca(2+) influx, and memory formation through mechanisms of synaptic plasticity. Recently, we have reported the mechanism of the synapse redox stress associated with NMDARs altered expression. We suggest that oxidative stress mediated through NMDAR and their interaction with other molecules might be a driving force for tau hyperphosphorylation and synapse dysfunction. Thus, understanding the oxidative stress mechanism and degenerating synapses is crucial for the development of therapeutic strategies designed to prevent AD pathogenesis.

摘要

突触由神经元间连接形成,使一个神经元细胞能够将电信号或化学信号传递给另一个细胞。在大多数神经退行性疾病中,这种信号传递通常会受损或丧失。人们普遍认为,突触功能障碍和突触丧失是导致阿尔茨海默病(AD)患者认知缺陷的原因。尽管AD的病理特征是老年斑、神经原纤维缠结和与氧化应激增加相关的神经元变性,但突触丧失是AD发病机制中的早期事件。丝裂原活化蛋白激酶(MAPK)、细胞外受体激酶(ERK)、钙调蛋白依赖性蛋白激酶(CaMKII)、糖原合酶-3β(GSK-3β)、cAMP反应元件结合蛋白(CREB)和钙调神经磷酸酶等主要激酶的参与与氧化应激介导的tau异常过度磷酸化动态相关,这表明这些激酶的改变可能专门参与了AD的发病机制。N-甲基-D-天冬氨酸(NMDA)受体(NMDAR)激活和β淀粉样蛋白(Aβ)毒性会改变突触功能,这也与蛋白磷酸酶(PP)抑制和tau过度磷酸化(AD的两个主要事件)相关。然而,氧化应激在突触功能障碍中的作用尚不清楚。大脑中的氧化应激和自由基生成以及兴奋性毒性会导致神经元细胞死亡。多项研究推断,氧化应激所引发的兴奋性毒性、自由基生成和突触功能改变与AD病理相关。NMDARs通过突触可塑性机制维持神经元兴奋性、Ca(2+)内流和记忆形成。最近,我们报道了与NMDARs表达改变相关的突触氧化还原应激机制。我们认为,通过NMDAR介导的氧化应激及其与其他分子的相互作用可能是tau过度磷酸化和突触功能障碍的驱动力。因此,了解氧化应激机制和退化的突触对于开发旨在预防AD发病机制的治疗策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/dbdfc2e988f1/nihms650978f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/50a3e0f1ddee/nihms650978f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/a9e20ed82a78/nihms650978f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/e73887ae3f70/nihms650978f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/6240e4e79555/nihms650978f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/dbdfc2e988f1/nihms650978f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/50a3e0f1ddee/nihms650978f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/a9e20ed82a78/nihms650978f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/e73887ae3f70/nihms650978f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/6240e4e79555/nihms650978f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d6/4470891/dbdfc2e988f1/nihms650978f5.jpg

相似文献

1
Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.阿尔茨海默病发病机制中的氧化应激与突触功能障碍:理解治疗策略
Mol Neurobiol. 2016 Jan;53(1):648-661. doi: 10.1007/s12035-014-9053-6. Epub 2014 Dec 17.
2
Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.在阿尔茨海默病模型中,丙戊酸通过糖原合酶激酶-3β信号通路改变突触结构并加速神经突生长。
CNS Neurosci Ther. 2015 Nov;21(11):887-97. doi: 10.1111/cns.12445. Epub 2015 Sep 19.
3
Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.链脲佐菌素脑室内注射诱导的神经毒性和脑胰岛素抵抗:对散发性阿尔茨海默病(sAD)样病理的治疗干预
Mol Neurobiol. 2016 Sep;53(7):4548-62. doi: 10.1007/s12035-015-9384-y. Epub 2015 Aug 23.
4
Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors.阿尔茨海默病中的功能障碍突触——聚焦于 NMDA 受体。
Neuropharmacology. 2014 Jan;76 Pt A:16-26. doi: 10.1016/j.neuropharm.2013.08.013. Epub 2013 Aug 22.
5
The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.阿尔茨海默病中氧化应激、tau蛋白过度磷酸化与自噬功能障碍之间的复杂关系
Oxid Med Cell Longev. 2015;2015:352723. doi: 10.1155/2015/352723. Epub 2015 Jun 15.
6
Dysfunction of NMDA receptors in Alzheimer's disease.阿尔茨海默病中N-甲基-D-天冬氨酸受体功能障碍
Neurol Sci. 2016 Jul;37(7):1039-47. doi: 10.1007/s10072-016-2546-5. Epub 2016 Mar 12.
7
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.从紊乱的大脑葡萄糖代谢解码阿尔茨海默病:对诊断和治疗策略的影响。
Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11.
8
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.寡聚淀粉样β蛋白诱导的阿尔茨海默病突触功能障碍。
Mol Neurodegener. 2014 Nov 14;9:48. doi: 10.1186/1750-1326-9-48.
9
Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.冈田酸诱导的大鼠脑中 Tau 磷酸化:NMDA 受体的作用。
Neuroscience. 2013 May 15;238:97-113. doi: 10.1016/j.neuroscience.2013.01.075. Epub 2013 Feb 13.
10
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.AD 突触处的一个 NH2 端 tau 片段靶向神经元线粒体:可能对神经退行性变的影响。
J Alzheimers Dis. 2010;21(2):445-70. doi: 10.3233/JAD-2010-100120.

引用本文的文献

1
Pathogenic synergy: dysfunctional mitochondria and neuroinflammation in neurodegenerative diseases associated with aging.致病性协同作用:衰老相关神经退行性疾病中的线粒体功能障碍与神经炎症
Front Aging. 2025 Aug 5;6:1615764. doi: 10.3389/fragi.2025.1615764. eCollection 2025.
2
Acceleration-Dependent Effects of Vibrotactile Gamma Stimulation on Cognitive Recovery and Cholinergic Function in a Scopolamine-Induced Neurotoxicity Mouse Model.在东莨菪碱诱导的神经毒性小鼠模型中,振动触觉γ刺激对认知恢复和胆碱能功能的加速度依赖性影响。
Biomedicines. 2025 Aug 20;13(8):2031. doi: 10.3390/biomedicines13082031.
3
Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer's disease: secondary analysis of a randomized clinical trial.

本文引用的文献

1
Mechanism of synapse redox stress in Okadaic acid (ICV) induced memory impairment: Role of NMDA receptor.冈田酸(脑室内注射)诱导记忆损伤中突触氧化还原应激的机制:N-甲基-D-天冬氨酸受体的作用
Neurochem Int. 2014 Oct;76:32-41. doi: 10.1016/j.neuint.2014.06.012. Epub 2014 Jun 28.
2
Synthesis of new lipoic acid conjugates and evaluation of their free radical scavenging and neuroprotective activities.新型硫辛酸缀合物的合成及其自由基清除和神经保护活性的评价。
Chem Biol Drug Des. 2014 Jun;83(6):688-96. doi: 10.1111/cbdd.12282. Epub 2014 May 12.
3
Glial activation and post-synaptic neurotoxicity: the key events in Streptozotocin (ICV) induced memory impairment in rats.
苯甲酸钠治疗可降低阿尔茨海默病患者的β淀粉样肽水平并改善认知功能:一项随机临床试验的二次分析
Transl Psychiatry. 2025 Aug 5;15(1):264. doi: 10.1038/s41398-025-03492-3.
4
Modulatory Effects of on Neurodegenerative Diseases: Unveiling the Latest Findings and Applications Related to Neuroinflammation, Oxidative Stress, and Cognitive Dysfunction.[具体物质名称]对神经退行性疾病的调节作用:揭示与神经炎症、氧化应激和认知功能障碍相关的最新发现及应用
Antioxidants (Basel). 2025 Jul 12;14(7):854. doi: 10.3390/antiox14070854.
5
Interplay Between Aging and Tau Pathology in Alzheimer's Disease: Mechanisms and Translational Perspectives.阿尔茨海默病中衰老与 Tau 病理的相互作用:机制与转化视角
Antioxidants (Basel). 2025 Jun 24;14(7):774. doi: 10.3390/antiox14070774.
6
Exo70 Protects Against Memory and Synaptic Impairments Following Mild Traumatic Brain Injury.Exo70可预防轻度创伤性脑损伤后的记忆和突触损伤。
Antioxidants (Basel). 2025 May 26;14(6):640. doi: 10.3390/antiox14060640.
7
Investigating the Synergistic Neuroprotective Effects of Plant-Derived Antioxidants and the Psychedelic N,N-Dimethyltryptamine in Alzheimer's Disease Therapy.研究植物源性抗氧化剂与致幻剂N,N-二甲基色胺在阿尔茨海默病治疗中的协同神经保护作用。
Cells. 2025 Jun 19;14(12):934. doi: 10.3390/cells14120934.
8
Multi-Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations.阿尔茨海默病治疗中的多靶点药物设计:新兴技术、优势、挑战与局限
Pharmacol Res Perspect. 2025 Aug;13(4):e70131. doi: 10.1002/prp2.70131.
9
Bilirubin: a game-changer in alzheimer's therapy? Unveiling its neuroprotective and disease-modifying potential.胆红素:阿尔茨海默病治疗的变革者?揭示其神经保护和疾病修饰潜力。
Metab Brain Dis. 2025 Jun 16;40(6):224. doi: 10.1007/s11011-025-01653-3.
10
Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease.神经炎症对阿尔茨海默病认知和运动障碍的双重影响。
J Alzheimers Dis Rep. 2025 Jun 2;9:25424823251341870. doi: 10.1177/25424823251341870. eCollection 2025 Jan-Dec.
胶质细胞激活和突触后神经毒性:链脲佐菌素(脑室注射)诱导大鼠记忆损伤的关键事件。
Pharmacol Biochem Behav. 2014 Feb;117:104-17. doi: 10.1016/j.pbb.2013.11.035. Epub 2013 Dec 10.
4
Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases.拉替拉嗪:在阿尔茨海默病和其他神经退行性疾病的潜在治疗作用中的分子机制。
Transl Psychiatry. 2013 Dec 3;3(12):e332. doi: 10.1038/tp.2013.97.
5
Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.设计、合成及生物评价亚胺白藜芦醇衍生物作为多靶点抗阿尔茨海默病药物。
Eur J Med Chem. 2014 Jan;71:36-45. doi: 10.1016/j.ejmech.2013.10.068. Epub 2013 Nov 4.
6
Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a 13C NMR study.通过脂酸在阿尔茨海默病三转基因小鼠模型中的代谢缺陷逆转:13C NMR 研究。
J Cereb Blood Flow Metab. 2014 Feb;34(2):288-96. doi: 10.1038/jcbfm.2013.196. Epub 2013 Nov 13.
7
Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model.阿尔茨海默病小鼠模型中淀粉样斑块附近的线粒体改变。
J Neurosci. 2013 Oct 23;33(43):17042-51. doi: 10.1523/JNEUROSCI.1836-13.2013.
8
A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease.ω-3 脂肪酸和 α-硫辛酸治疗阿尔茨海默病的随机安慰剂对照初步试验。
J Alzheimers Dis. 2014;38(1):111-20. doi: 10.3233/JAD-130722.
9
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain.阿尔茨海默病大脑中硫辛酸被HNE氧化修饰的情况。
Redox Biol. 2013 Jan 30;1(1):80-5. doi: 10.1016/j.redox.2013.01.002. eCollection 2013.
10
Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease.设计、合成及评价用于治疗阿尔茨海默病的多靶标导向白藜芦醇衍生物。
J Med Chem. 2013 Jul 25;56(14):5843-59. doi: 10.1021/jm400567s. Epub 2013 Jul 8.